FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
Links shared publicly online about this topic.
- 985total visits
FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 2:34 am By:
FDA Alert - FDA Warns of Eosinophilic Pneumonia Risk with Cubicin (daptomycin) - http://bit.ly/d3yDrx
Eosinophilic Pneumonia Linked With Cubicin Use
medicalnewstoday.com — “FDA releases drug safety communication warning of potential to acquire this serious condition when receiving intravenous antibacterial daptomycin.Patients and health professionals have” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 12:05 pm By:
MNT Infect Diseases Health News
Eosinophilic Pneumonia Linked With Cubicin Use http://mnt.to/3GSp #viruses #bacteria
Advertisement
